As noted by others ( Of note, the finding of a markedly greater benefit on HF of efpeglenatide amongst trial participants using SGLT2 inhibitors at enrolment in the AMPLITUDE-O CVOT highlights another important point ( Another drug class widely used to treat type 2 diabetes is inhibitors of the enzyme dipeptidyl peptidase-4 (DPP4), which mediates enzymatic breakdown of GLP-1
Studies tracking people on regular semaglutide therapy show steady reductions in hunger, food cravings, and daily calorie intake when doses remain consistent
Acta Diabetol 2015;52:83744
GLP-1 receptor agonistsincluding semaglutide, dulaglutide, and liraglutideare widely prescribed for type 2 diabetes and weight management
Widely used GLP-1based medications such as Ozempic and Mounjaroprimarily for Type 2 Diabetes and weight lossare now being explored for broader therapeutic applications
Should I stop taking my GLP-1 if I feel too tired